Asymptomatic Soft Tumor on the Forearm

Article Type
Changed
Tue, 05/02/2023 - 13:49
Display Headline
Asymptomatic Soft Tumor on the Forearm

The Diagnosis: Aneurysmal Dermatofibroma

A shave biopsy of the entire tumor was performed at the initial visit. Histologic examination with hematoxylin and eosin staining revealed a fibrohistiocytic infiltrate containing cleftlike cavernous spaces lined by epithelial cells (Figure, A). Immunohistochemical staining revealed factor XIIIa expression on fibrohistiocytic cells (Figure, B). CD34 was expressed on vascular endothelial cells, but it failed to highlight the fibrohistiocytic space (Figure, C). Overall, these findings supported the diagnosis of aneurysmal dermatofibroma. The lesion healed without complications, and the patient was counseled on the risk for recurrence. He was offered localized excision but opted for conservative management without excision and close follow-up and monitoring.

Findings from a shave biopsy of the right forearm tumor supported the diagnosis of aneurysmal dermatofibroma.
Findings from a shave biopsy of the right forearm tumor supported the diagnosis of aneurysmal dermatofibroma. A, Hematoxylin and eosin staining revealed a fibrohistiocytic infiltrate containing cleftlike cavernous spaces lined by epithelial cells (original magnification ×40). B, Immunohistochemical staining for factor XIIIa diffusely highlighted the fibrohistiocytic infiltrate (original magnification ×40). C, Immunohistochemical staining for endothelial cell marker CD34 highlighted cavernous spaces (original magnification ×100).

Dermatofibromas are common benign cutaneous nodules that often are asymptomatic and occur on the extremities. Dermatofibromas also are known as cutaneous fibrous histiocytomas and have numerous histologic variants. Aneurysmal dermatofibroma (also called aneurysmal fibrous histiocytoma) is a rare histologic variant of dermatofibroma presenting as a slow-growing exophytic tumor that can be purple, red, brown, or blue. Although classic dermatofibromas typically constitute a straightforward diagnosis, aneurysmal dermatofibromas often are more challenging to clinically differentiate from other cutaneous neoplasms. Additionally, due to the exophytic nature and larger size (0.5–4.0 cm), aneurysmal dermatofibromas do not exhibit the characteristic dimple (Fitzpatrick) sign found in many dermatofibromas. Aneurysmal dermatofibromas are 10 times more likely to recur than classic dermatofibromas.1-4

Aneurysmal dermatofibromas can mimic other cutaneous neoplasms, some indolent and others more aggressive. Similar to aneurysmal dermatofibromas, solitary neurofibromas and nevi lipomatosus can appear as asymptomatic exophytic nodules with a similar spectrum of color and indolent clinical courses. In nevus lipomatosus, the dermis is almost entirely replaced by mature adipose tissue.5 Solitary neurofibromas represent a proliferation of neuromesenchymal cells with haphazardly arranged, wavy nuclei characteristic of nerve cells.6 Dermatofibrosarcoma protuberans can be distinguished from aneurysmal dermatofibroma by lack of factor XIIIa expression and diffuse positivity for CD34.7 Finally, aneurysmal dermatofibromas may resemble vascular tumors such as nodular Kaposi sarcoma. Kaposi sarcoma can be differentiated from an aneurysmal dermatofibroma by the presence of characteristic vascular wrapping, the absence of fibrohistiocytic cells, and expression of human herpesvirus 8 latent nuclear antigen-1.1,8 Although aneurysmal dermatofibromas are of low malignant potential, they are associated with a higher rate of recurrence compared to common dermatofibromas.9 Definitive treatment involves complete excision with follow-up to ensure no signs of recurrence.10 Incomplete excision can increase the likelihood of recurrence, especially for larger aneurysmal dermatofibromas. Aneurysmal dermatofibromas are one of the subtypes of dermatofibromas that may extend into the subcutaneous tissue. Han et al2 found that 77.8% of aneurysmal dermatofibromas extended into subcutaneous tissue. Recognizing the clinical and pathological features of this rare subtype of dermatofibroma can aid dermatologists in appropriate recognition and management.

References
  1. Burr DM, Peterson WA, Peterson MW. Aneurysmal fibrous histiocytoma: a case report and review of the literature. J Am Osteopath. June 2018;40. Accessed February 14, 2023. https://cdn.ymaws.com/www.aocd.org/resource/resmgr/jaocd/contents/volume40/40-04.pdf
  2. Han TY, Chang HS, Lee JHK, et al. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann Dermatol. 2011;23:185-192.
  3. Morariu SH, Suciu M, Vartolomei MD, et al. Aneurysmal dermatofibroma mimicking both clinical and dermoscopic malignant melanoma and Kaposi’s sarcoma. Rom J Morphol Embryol. 2014;55:1221-1224.
  4. Calonje E, Fletcher CDM. Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm. Histopathology. 1995;26:323-331.
  5. Pujani M, Choudhury M, Garg T, et al. Nevus lipomatosus superficialis: a rare cutaneous hamartoma. Indian Dermatol Online J. 2014;5:109-110.
  6. Strike SA, Puhaindran ME. Nerve tumors of the upper extremity. Clin Plast Surg. 2019;46:347-350.
  7. Cohen PR, Rapini RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa. Am J Dermatopathol. 1994;16:573-574.
  8. Kandal S, Ozmen S, Demir HY, et al. Aneurysmal fibrous histiocytoma of the skin: a rare variant of dermatofibroma. Plast Reconstr Surg. 2005;116:2050-2051.
  9. Hornick JL. Cutaneous soft tissue tumors: how do we make sense of fibrous and “fibrohistiocytic” tumors with confusing names and similar appearances? Mod Pathol. 2020;33:56-65.
  10. Das A, Das A, Bandyopadhyay D, et al. Aneurysmal benign fibrous histiocytoma presenting as a giant acrochordon on thigh. Indian Dermatol Online J. 2015;6:436.
Article PDF
Author and Disclosure Information

From the Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Drs. Romisher and Albornoz report no conflict of interest. Dr. Nikbakht is supported by a Skin Cancer Foundation Todd Nagel Memorial Research Grant.

Correspondence: Neda Nikbakht, MD, PhD, Department of Dermatology and Cutaneous Biology, 233 S 10th St, Room 410, Philadelphia, PA 19107 (neda.nikbakht@jefferson.edu).

Issue
Cutis - 111(2)
Publications
Topics
Page Number
E4-E6
Sections
Author and Disclosure Information

From the Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Drs. Romisher and Albornoz report no conflict of interest. Dr. Nikbakht is supported by a Skin Cancer Foundation Todd Nagel Memorial Research Grant.

Correspondence: Neda Nikbakht, MD, PhD, Department of Dermatology and Cutaneous Biology, 233 S 10th St, Room 410, Philadelphia, PA 19107 (neda.nikbakht@jefferson.edu).

Author and Disclosure Information

From the Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Drs. Romisher and Albornoz report no conflict of interest. Dr. Nikbakht is supported by a Skin Cancer Foundation Todd Nagel Memorial Research Grant.

Correspondence: Neda Nikbakht, MD, PhD, Department of Dermatology and Cutaneous Biology, 233 S 10th St, Room 410, Philadelphia, PA 19107 (neda.nikbakht@jefferson.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Aneurysmal Dermatofibroma

A shave biopsy of the entire tumor was performed at the initial visit. Histologic examination with hematoxylin and eosin staining revealed a fibrohistiocytic infiltrate containing cleftlike cavernous spaces lined by epithelial cells (Figure, A). Immunohistochemical staining revealed factor XIIIa expression on fibrohistiocytic cells (Figure, B). CD34 was expressed on vascular endothelial cells, but it failed to highlight the fibrohistiocytic space (Figure, C). Overall, these findings supported the diagnosis of aneurysmal dermatofibroma. The lesion healed without complications, and the patient was counseled on the risk for recurrence. He was offered localized excision but opted for conservative management without excision and close follow-up and monitoring.

Findings from a shave biopsy of the right forearm tumor supported the diagnosis of aneurysmal dermatofibroma.
Findings from a shave biopsy of the right forearm tumor supported the diagnosis of aneurysmal dermatofibroma. A, Hematoxylin and eosin staining revealed a fibrohistiocytic infiltrate containing cleftlike cavernous spaces lined by epithelial cells (original magnification ×40). B, Immunohistochemical staining for factor XIIIa diffusely highlighted the fibrohistiocytic infiltrate (original magnification ×40). C, Immunohistochemical staining for endothelial cell marker CD34 highlighted cavernous spaces (original magnification ×100).

Dermatofibromas are common benign cutaneous nodules that often are asymptomatic and occur on the extremities. Dermatofibromas also are known as cutaneous fibrous histiocytomas and have numerous histologic variants. Aneurysmal dermatofibroma (also called aneurysmal fibrous histiocytoma) is a rare histologic variant of dermatofibroma presenting as a slow-growing exophytic tumor that can be purple, red, brown, or blue. Although classic dermatofibromas typically constitute a straightforward diagnosis, aneurysmal dermatofibromas often are more challenging to clinically differentiate from other cutaneous neoplasms. Additionally, due to the exophytic nature and larger size (0.5–4.0 cm), aneurysmal dermatofibromas do not exhibit the characteristic dimple (Fitzpatrick) sign found in many dermatofibromas. Aneurysmal dermatofibromas are 10 times more likely to recur than classic dermatofibromas.1-4

Aneurysmal dermatofibromas can mimic other cutaneous neoplasms, some indolent and others more aggressive. Similar to aneurysmal dermatofibromas, solitary neurofibromas and nevi lipomatosus can appear as asymptomatic exophytic nodules with a similar spectrum of color and indolent clinical courses. In nevus lipomatosus, the dermis is almost entirely replaced by mature adipose tissue.5 Solitary neurofibromas represent a proliferation of neuromesenchymal cells with haphazardly arranged, wavy nuclei characteristic of nerve cells.6 Dermatofibrosarcoma protuberans can be distinguished from aneurysmal dermatofibroma by lack of factor XIIIa expression and diffuse positivity for CD34.7 Finally, aneurysmal dermatofibromas may resemble vascular tumors such as nodular Kaposi sarcoma. Kaposi sarcoma can be differentiated from an aneurysmal dermatofibroma by the presence of characteristic vascular wrapping, the absence of fibrohistiocytic cells, and expression of human herpesvirus 8 latent nuclear antigen-1.1,8 Although aneurysmal dermatofibromas are of low malignant potential, they are associated with a higher rate of recurrence compared to common dermatofibromas.9 Definitive treatment involves complete excision with follow-up to ensure no signs of recurrence.10 Incomplete excision can increase the likelihood of recurrence, especially for larger aneurysmal dermatofibromas. Aneurysmal dermatofibromas are one of the subtypes of dermatofibromas that may extend into the subcutaneous tissue. Han et al2 found that 77.8% of aneurysmal dermatofibromas extended into subcutaneous tissue. Recognizing the clinical and pathological features of this rare subtype of dermatofibroma can aid dermatologists in appropriate recognition and management.

The Diagnosis: Aneurysmal Dermatofibroma

A shave biopsy of the entire tumor was performed at the initial visit. Histologic examination with hematoxylin and eosin staining revealed a fibrohistiocytic infiltrate containing cleftlike cavernous spaces lined by epithelial cells (Figure, A). Immunohistochemical staining revealed factor XIIIa expression on fibrohistiocytic cells (Figure, B). CD34 was expressed on vascular endothelial cells, but it failed to highlight the fibrohistiocytic space (Figure, C). Overall, these findings supported the diagnosis of aneurysmal dermatofibroma. The lesion healed without complications, and the patient was counseled on the risk for recurrence. He was offered localized excision but opted for conservative management without excision and close follow-up and monitoring.

Findings from a shave biopsy of the right forearm tumor supported the diagnosis of aneurysmal dermatofibroma.
Findings from a shave biopsy of the right forearm tumor supported the diagnosis of aneurysmal dermatofibroma. A, Hematoxylin and eosin staining revealed a fibrohistiocytic infiltrate containing cleftlike cavernous spaces lined by epithelial cells (original magnification ×40). B, Immunohistochemical staining for factor XIIIa diffusely highlighted the fibrohistiocytic infiltrate (original magnification ×40). C, Immunohistochemical staining for endothelial cell marker CD34 highlighted cavernous spaces (original magnification ×100).

Dermatofibromas are common benign cutaneous nodules that often are asymptomatic and occur on the extremities. Dermatofibromas also are known as cutaneous fibrous histiocytomas and have numerous histologic variants. Aneurysmal dermatofibroma (also called aneurysmal fibrous histiocytoma) is a rare histologic variant of dermatofibroma presenting as a slow-growing exophytic tumor that can be purple, red, brown, or blue. Although classic dermatofibromas typically constitute a straightforward diagnosis, aneurysmal dermatofibromas often are more challenging to clinically differentiate from other cutaneous neoplasms. Additionally, due to the exophytic nature and larger size (0.5–4.0 cm), aneurysmal dermatofibromas do not exhibit the characteristic dimple (Fitzpatrick) sign found in many dermatofibromas. Aneurysmal dermatofibromas are 10 times more likely to recur than classic dermatofibromas.1-4

Aneurysmal dermatofibromas can mimic other cutaneous neoplasms, some indolent and others more aggressive. Similar to aneurysmal dermatofibromas, solitary neurofibromas and nevi lipomatosus can appear as asymptomatic exophytic nodules with a similar spectrum of color and indolent clinical courses. In nevus lipomatosus, the dermis is almost entirely replaced by mature adipose tissue.5 Solitary neurofibromas represent a proliferation of neuromesenchymal cells with haphazardly arranged, wavy nuclei characteristic of nerve cells.6 Dermatofibrosarcoma protuberans can be distinguished from aneurysmal dermatofibroma by lack of factor XIIIa expression and diffuse positivity for CD34.7 Finally, aneurysmal dermatofibromas may resemble vascular tumors such as nodular Kaposi sarcoma. Kaposi sarcoma can be differentiated from an aneurysmal dermatofibroma by the presence of characteristic vascular wrapping, the absence of fibrohistiocytic cells, and expression of human herpesvirus 8 latent nuclear antigen-1.1,8 Although aneurysmal dermatofibromas are of low malignant potential, they are associated with a higher rate of recurrence compared to common dermatofibromas.9 Definitive treatment involves complete excision with follow-up to ensure no signs of recurrence.10 Incomplete excision can increase the likelihood of recurrence, especially for larger aneurysmal dermatofibromas. Aneurysmal dermatofibromas are one of the subtypes of dermatofibromas that may extend into the subcutaneous tissue. Han et al2 found that 77.8% of aneurysmal dermatofibromas extended into subcutaneous tissue. Recognizing the clinical and pathological features of this rare subtype of dermatofibroma can aid dermatologists in appropriate recognition and management.

References
  1. Burr DM, Peterson WA, Peterson MW. Aneurysmal fibrous histiocytoma: a case report and review of the literature. J Am Osteopath. June 2018;40. Accessed February 14, 2023. https://cdn.ymaws.com/www.aocd.org/resource/resmgr/jaocd/contents/volume40/40-04.pdf
  2. Han TY, Chang HS, Lee JHK, et al. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann Dermatol. 2011;23:185-192.
  3. Morariu SH, Suciu M, Vartolomei MD, et al. Aneurysmal dermatofibroma mimicking both clinical and dermoscopic malignant melanoma and Kaposi’s sarcoma. Rom J Morphol Embryol. 2014;55:1221-1224.
  4. Calonje E, Fletcher CDM. Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm. Histopathology. 1995;26:323-331.
  5. Pujani M, Choudhury M, Garg T, et al. Nevus lipomatosus superficialis: a rare cutaneous hamartoma. Indian Dermatol Online J. 2014;5:109-110.
  6. Strike SA, Puhaindran ME. Nerve tumors of the upper extremity. Clin Plast Surg. 2019;46:347-350.
  7. Cohen PR, Rapini RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa. Am J Dermatopathol. 1994;16:573-574.
  8. Kandal S, Ozmen S, Demir HY, et al. Aneurysmal fibrous histiocytoma of the skin: a rare variant of dermatofibroma. Plast Reconstr Surg. 2005;116:2050-2051.
  9. Hornick JL. Cutaneous soft tissue tumors: how do we make sense of fibrous and “fibrohistiocytic” tumors with confusing names and similar appearances? Mod Pathol. 2020;33:56-65.
  10. Das A, Das A, Bandyopadhyay D, et al. Aneurysmal benign fibrous histiocytoma presenting as a giant acrochordon on thigh. Indian Dermatol Online J. 2015;6:436.
References
  1. Burr DM, Peterson WA, Peterson MW. Aneurysmal fibrous histiocytoma: a case report and review of the literature. J Am Osteopath. June 2018;40. Accessed February 14, 2023. https://cdn.ymaws.com/www.aocd.org/resource/resmgr/jaocd/contents/volume40/40-04.pdf
  2. Han TY, Chang HS, Lee JHK, et al. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann Dermatol. 2011;23:185-192.
  3. Morariu SH, Suciu M, Vartolomei MD, et al. Aneurysmal dermatofibroma mimicking both clinical and dermoscopic malignant melanoma and Kaposi’s sarcoma. Rom J Morphol Embryol. 2014;55:1221-1224.
  4. Calonje E, Fletcher CDM. Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm. Histopathology. 1995;26:323-331.
  5. Pujani M, Choudhury M, Garg T, et al. Nevus lipomatosus superficialis: a rare cutaneous hamartoma. Indian Dermatol Online J. 2014;5:109-110.
  6. Strike SA, Puhaindran ME. Nerve tumors of the upper extremity. Clin Plast Surg. 2019;46:347-350.
  7. Cohen PR, Rapini RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa. Am J Dermatopathol. 1994;16:573-574.
  8. Kandal S, Ozmen S, Demir HY, et al. Aneurysmal fibrous histiocytoma of the skin: a rare variant of dermatofibroma. Plast Reconstr Surg. 2005;116:2050-2051.
  9. Hornick JL. Cutaneous soft tissue tumors: how do we make sense of fibrous and “fibrohistiocytic” tumors with confusing names and similar appearances? Mod Pathol. 2020;33:56-65.
  10. Das A, Das A, Bandyopadhyay D, et al. Aneurysmal benign fibrous histiocytoma presenting as a giant acrochordon on thigh. Indian Dermatol Online J. 2015;6:436.
Issue
Cutis - 111(2)
Issue
Cutis - 111(2)
Page Number
E4-E6
Page Number
E4-E6
Publications
Publications
Topics
Article Type
Display Headline
Asymptomatic Soft Tumor on the Forearm
Display Headline
Asymptomatic Soft Tumor on the Forearm
Sections
Questionnaire Body

A 43-year-old Black man with no notable medical history presented to our clinic with a progressively enlarging tumor on the right forearm of 12 months’ duration. Despite its progressive growth, the tumor was asymptomatic. Physical examination of the right forearm revealed a 3.7×3.0-cm, well-circumscribed, exophytic tumor with a mildly erythematous hue, scaly surface, and rubbery consistency. There was no surrounding erythema, edema, localized lymphadenopathy, or concurrent lymphedema.

Asymptomatic soft tumor on the forearm

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 02/15/2023 - 09:00
Un-Gate On Date
Wed, 02/15/2023 - 09:00
Use ProPublica
CFC Schedule Remove Status
Wed, 02/15/2023 - 09:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Article PDF Media